Clinical Trial Update: Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of Z160 in adults with postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Z160

Snippet

Sponsor: Zalicus | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED